Papers in Pneumonia
Page 3 · newest first
- Estimated incidence of respiratory hospitalizations attributable to RSV infections across age and socioeconomic groupsPneumonia · 2022
- The remarkable history of pneumococcal vaccination: an ongoing challengePneumonia · 2022
- Multi-drug resistant gram-negative bacterial pneumonia: etiology, risk factors, and drug resistance patternsPneumonia · 2022
- Antibiotic prescription rationality and associated in-patient treatment outcomes in children under-five with severe pneumonia at Bwizibwera health center IV, Mbarara District, South-Western UgandaPneumonia · 2022
- Additional effect of azithromycin over β-lactam alone for severe community-acquired pneumonia-associated acute respiratory distress syndrome: a retrospective cohort studyPneumonia · 2022
- Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic managementPneumonia · 2021
- Identified micro-organisms in hospitalized community-acquired pneumonia patients living near goat and poultry farmsPneumonia · 2021
- Candida species in community-acquired pneumonia in patients with chronic aspirationPneumonia · 2021
- Serotype distribution of invasive, non-invasive and carried Streptococcus pneumoniae in Malaysia: a meta-analysisPneumonia · 2021
- Association of nasopharyngeal viruses and pathogenic bacteria in children and their parents with and without HIVPneumonia · 2021
- The role of co-infections and secondary infections in patients with COVID-19Pneumonia · 2021
- Effect of prophylactic administration of antipyretics on the immune response to pneumococcal conjugate vaccines in children: a systematic reviewPneumonia · 2021
- Carriage of upper respiratory tract pathogens in rural communities of Sarawak, Malaysian BorneoPneumonia · 2021
- The expansive effects of polyamines on the metabolism and virulence of Streptococcus pneumoniaePneumonia · 2021
- HSV-pneumonitis in a patient with lung cancer receiving check point inhibitors – a case reportPneumonia · 2021
- Legionnaires’ disease in the time of COVID-19Pneumonia · 2021
- Determinants of community acquired pneumonia among 2 to 59 months of age children in Northeast Ethiopia: a case-control studyPneumonia · 2020
- An observational study of the reactogenicity and immunogenicity of 13-valent pneumococcal conjugate vaccine in women of childbearing age in Papua New GuineaPneumonia · 2020
- E-cigarette, or vaping, product use-associated lung injury: a reviewPneumonia · 2020
- Etiology of community-acquired pneumonia in adults: a systematic reviewPneumonia · 2020
- Variation in clinical outcomes and process of care measures in community acquired pneumonia: a systematic reviewPneumonia · 2020
- Tuberculosis in migrants – screening, surveillance and ethicsPneumonia · 2020
- Community acquired paediatric pneumonia; experience from a pneumococcal vaccine- naive populationPneumonia · 2020
- Prevalence of gram negative bacteria causing community acquired pneumonia among adults in Mwanza City, TanzaniaPneumonia · 2020
- Validation for using electronic health records to identify community acquired pneumonia hospitalization among people with and without HIVPneumonia · 2020
- Clinical characteristics and outcomes of patients with H1N1 influenza pneumonia admitted at a tertiary care hospital in Karachi, PakistanPneumonia · 2020
- Measuring accuracy of plethysmography based respiratory rate measurement using pulse oximeter at a tertiary hospital in IndiaPneumonia · 2020
- Promoting the use of social networks in pneumoniaPneumonia · 2020
- The impact of certain underlying comorbidities on the risk of developing hospitalised pneumonia in EnglandPneumonia · 2019
- Meningococcal pneumonia: a reviewPneumonia · 2019
- Treatment of community-onset pneumonia in neutropenic cancer patients: β-lactam monotherapy versus combination antibiotic regimensPneumonia · 2019
- Risk factors associated with nasopharyngeal carriage and density of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus in young children living in IndonesiaPneumonia · 2018
- Inter-hospital variation in the utilization of diagnostics and their proportionality in the management of adult community-acquired pneumoniaPneumonia · 2018
- Impact of the 23-valent pneumococcal polysaccharide vaccination in pregnancy against infant acute lower respiratory infections in the Northern Territory of AustraliaPneumonia · 2018
- Streptococcus pneumoniae outbreaks and implications for transmission and control: a systematic reviewPneumonia · 2018
- Corynebacteria as a cause of pulmonary infection: a case series and literature reviewPneumonia · 2018
- Decreased relative risk of pneumococcal pneumonia during the last decade, a nested case-control studyPneumonia · 2018
- How low can we go? The implications of low bacterial load in respiratory microbiota studiesPneumonia · 2018
- Lung function in HIV-infected children and adolescentsPneumonia · 2018
- Anti-protein immunoglobulin M responses to pneumococcus are not associated with agingPneumonia · 2018
- Rapid molecular assays for detection of tuberculosisPneumonia · 2018
- Cilostazol for the prevention of pneumonia: a systematic reviewPneumonia · 2018
- The association between pre-hospital antibiotic therapy and subsequent in-hospital mortality in adults presenting with community-acquired pneumonia: an observational studyPneumonia · 2018
- Pneumococcal vaccination in older persons: where are we today?Pneumonia · 2018
- Rationale and methods of a randomized controlled trial of immunogenicity, safety and impact on carriage of pneumococcal conjugate and polysaccharide vaccines in infants in Papua New GuineaPneumonia · 2017
- Economic burden of community-acquired pneumonia among elderly patients: a Japanese perspectivePneumonia · 2017
- Risk factors for community-acquired pneumonia among adults in Kenya: a case–control studyPneumonia · 2017
- Community-acquired pneumonia in the United Kingdom: a call to actionPneumonia · 2017
- Predictors of pneumococcal carriage and the effect of the 13-valent pneumococcal conjugate vaccination in the Western Australian Aboriginal populationAustralasian Journal of Paramedicine · 2017
- Pharmacologic inhibition of MEK1/2 reduces lung inflammation without impairing bacterial clearance in experimental Pseudomonas aeruginosa pneumoniaPneumonia · 2017